GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Cash Flow from Discontinued Operations

Aadi Bioscience (FRA:3350) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Aadi Bioscience's cash flow from discontinued operations for the three months ended in Mar. 2024 was €0.00 Mil. It means Aadi Bioscience received €0.00 Mil from the sale of part of business quarterly. Aadi Bioscience's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

Aadi Bioscience Cash Flow from Discontinued Operations Historical Data

The historical data trend for Aadi Bioscience's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Cash Flow from Discontinued Operations Chart

Aadi Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
- - - -

Aadi Bioscience Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aadi Bioscience Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aadi Bioscience Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
AAGH SGMO SEER GOSS CYT NYMXF PROK PRLD ABOS MLEC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
AADI:USA 3350:Germany
Address
17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272
Website
https://www.aadibio.com
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines